Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma.

Sun JY, Shen J, Thibodeaux J, Huang G, Wang Y, Gao J, Low PS, Dimitrov DS, Sumer BD.

Laryngoscope. 2014 Aug;124(8):E312-9. doi: 10.1002/lary.24606. Epub 2014 Mar 4.

PMID:
24448885
2.

Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque.

Jager NA, Westra J, van Dam GM, Teteloshvili N, Tio RA, Breek JC, Slart RH, Boersma H, Low PS, Bijl M, Zeebregts CJ.

J Nucl Med. 2012 Aug;53(8):1222-9. doi: 10.2967/jnumed.111.099671. Epub 2012 Jun 29.

3.

Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.

Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR.

Mol Cancer Ther. 2007 Apr;6(4):1230-8.

4.

Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer.

Müller A, Beck K, Rancic Z, Müller C, Fischer CR, Betzel T, Kaufmann PA, Schibli R, Krämer SD, Ametamey SM.

Mol Imaging. 2014;13:1-11.

PMID:
24622812
5.

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.

Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR.

Clin Cancer Res. 2004 Oct 15;10(20):7079-87.

6.

Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.

Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E, Nashi N, Hasselman J, Whitney M, Myers JN, Lippman SM, Tsien RY, Ideker T, Nguyen QT.

Otolaryngol Head Neck Surg. 2014 Oct;151(4):612-8. doi: 10.1177/0194599814545083. Epub 2014 Aug 4.

7.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ.

J Natl Cancer Inst. 1998 Jun 3;90(11):824-32.

PMID:
9625170
9.

In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice.

Yang K, Zhao C, Cao YA, Tang H, Bai YL, Huang H, Zhao CR, Chen R, Zhao D.

Oncol Rep. 2012 Jun;27(6):1925-31. doi: 10.3892/or.2012.1705. Epub 2012 Feb 29.

PMID:
22378320
10.

Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.

de Boer E, Crane LM, van Oosten M, van der Vegt B, van der Sluis T, Kooijman P, Low PS, van der Zee AG, Arts HJ, van Dam GM, Bart J.

PLoS One. 2015 Aug 6;10(8):e0135012. doi: 10.1371/journal.pone.0135012. eCollection 2015.

12.

Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.

Xu L, Yeudall WA, Yang H.

Acta Biomater. 2017 Jul 15;57:251-261. doi: 10.1016/j.actbio.2017.04.023. Epub 2017 Apr 22.

PMID:
28438704
13.

111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.

van Dijk LK, Hoeben BA, Stegeman H, Kaanders JH, Franssen GM, Boerman OC, Bussink J.

Radiother Oncol. 2013 Sep;108(3):484-8. doi: 10.1016/j.radonc.2013.06.034. Epub 2013 Aug 7.

PMID:
23932156
14.

Human-in-mouse modeling of primary head and neck squamous cell carcinoma.

Law JH, Whigham AS, Wirth PS, Liu D, Pham MQ, Vadivelu S, Kirkbride KC, Brown BT, Burkey BB, Sinard RJ, Netterville JL, Yarbrough WG.

Laryngoscope. 2009 Dec;119(12):2315-23. doi: 10.1002/lary.20607.

PMID:
19693929
15.

A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.

Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, Low PS.

J Nucl Med. 2012 Jul;53(7):1127-34. doi: 10.2967/jnumed.111.099390. Epub 2012 Jun 12.

16.

Phospholipid metabolite expression by head and neck squamous cell carcinoma.

Mann EA, Spiro JD, Chen LL, Kreutzer DL.

Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):763-9.

PMID:
8018329
17.

Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.

Xie W, Bharathy S, Kim D, Haffty BG, Rimm DL, Reiss M.

Oncol Res. 2003;14(2):61-73.

PMID:
14649540
18.

Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.

Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H.

Mod Pathol. 1997 Nov;10(11):1128-33.

PMID:
9388064
19.

Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.

Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.

Clin Cancer Res. 2005 May 1;11(9):3191-7.

20.

Optical imaging predicts tumor response to anti-EGFR therapy.

Helman EE, Newman JR, Dean NR, Zhang W, Zinn KR, Rosenthal EL.

Cancer Biol Ther. 2010 Jul 15;10(2):166-71.

Supplemental Content

Support Center